Shinhan Financial Group has teamed up with a guarantee institution and academia to support the global expansion of promising domestic bio ventures.
On June 26, during the 'K-Bio Global Innovation Forum' held in San Diego, Shinhan Financial Group announced it had signed a memorandum of understanding with the Korea Credit Guarantee Fund and Seoul National University Hospital to jointly discover and nurture global K-bio ventures.
The three organizations aim to enhance investment attraction and technological collaboration opportunities for domestic bio ventures by linking them with the global bio innovation ecosystem. Shinhan Financial will provide investments and loans to the bio ventures identified through this collaboration, while the Korea Credit Guarantee Fund will offer guarantees. Seoul National University Hospital will be responsible for research and development infrastructure and technical support. They will also collaborate on consulting and networking for overseas market entry. This partnership is expected to accelerate the global scaling of domestic bio ventures.
Shinhan Financial plans to continue expanding its financial support for the bio sector. Since 2018, Shinhan Asset Management has invested approximately 3 trillion won in the bio field through the Shinhan Startup Venture Fund. This year, the group plans to establish the eighth Shinhan Startup Venture Fund and introduce an additional 50 billion won dedicated bio fund managed by Shinhan Venture Investment.
On June 26, during the 'K-Bio Global Innovation Forum' held in San Diego, Shinhan Financial Group announced it had signed a memorandum of understanding with the Korea Credit Guarantee Fund and Seoul National University Hospital to jointly discover and nurture global K-bio ventures.
The three organizations aim to enhance investment attraction and technological collaboration opportunities for domestic bio ventures by linking them with the global bio innovation ecosystem. Shinhan Financial will provide investments and loans to the bio ventures identified through this collaboration, while the Korea Credit Guarantee Fund will offer guarantees. Seoul National University Hospital will be responsible for research and development infrastructure and technical support. They will also collaborate on consulting and networking for overseas market entry. This partnership is expected to accelerate the global scaling of domestic bio ventures.
Shinhan Financial plans to continue expanding its financial support for the bio sector. Since 2018, Shinhan Asset Management has invested approximately 3 trillion won in the bio field through the Shinhan Startup Venture Fund. This year, the group plans to establish the eighth Shinhan Startup Venture Fund and introduce an additional 50 billion won dedicated bio fund managed by Shinhan Venture Investment.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.